[Form 4] Evolus, Inc. Insider Trading Activity
Insider sale under 10b5-1 plan: Tomoko Yamagishi-Dressler, Chief Marketing Officer and director at Evolus, Inc. (EOLS), reported the sale of 5,722 shares of the company's common stock on 08/22/2025 at a price of $7.51 per share. After the transaction, the reporting person beneficially owned 89,949 shares. The filing indicates the sale was made pursuant to a Rule 10b5-1 trading plan and that the shares sold were required to be sold to cover tax withholding obligations arising from the vesting of restricted stock units.
Form and signature: The Form 4 was executed by an attorney-in-fact on behalf of the reporting person and includes the standard certification language required by Section 16 filings.
Vendita da insider in base al piano 10b5-1: Tomoko Yamagishi-Dressler, Chief Marketing Officer e amministratore di Evolus, Inc. (EOLS), ha comunicato la vendita di 5.722 azioni della società in data 22/08/2025 al prezzo di $7,51 per azione. Dopo l'operazione, la persona che ha presentato la comunicazione deteneva beneficiariamente 89.949 azioni. La segnalazione specifica che la vendita è avvenuta ai sensi di un piano di negoziazione secondo la Rule 10b5-1 e che le azioni vendute erano necessarie per coprire obblighi fiscali derivanti dal consolidamento di restricted stock units.
Modulo e firma: Il modulo Form 4 è stato firmato da un procuratore in nome della persona che ha presentato la comunicazione e contiene la consueta dichiarazione di certificazione richiesta per le comunicazioni ai sensi della Sezione 16.
Venta de insider bajo un plan 10b5-1: Tomoko Yamagishi-Dressler, directora y Chief Marketing Officer de Evolus, Inc. (EOLS), informó la venta de 5.722 acciones ordinarias de la compañía el 22/08/2025 a $7,51 por acción. Tras la transacción, la persona informante poseía beneficiariamente 89.949 acciones. La presentación indica que la venta se realizó conforme a un plan de negociación bajo la Regla 10b5-1 y que las acciones vendidas fueron necesarias para cubrir retenciones fiscales derivadas del otorgamiento de unidades de acciones restringidas (RSU).
Formulario y firma: El Formulario 4 fue ejecutado por un apoderado en nombre de la persona informante e incluye el lenguaje de certificación estándar exigido para las presentaciones conforme a la Sección 16.
10b5-1 계획에 따른 내부자 매도: Evolus, Inc.(EOLS)의 최고마케팅책임자 겸 이사인 Tomoko Yamagishi-Dressler는 2025년 8월 22일 회사 보통주 5,722주를 주당 $7.51에 매도한 사실을 보고했습니다. 거래 후 보고인은 89,949주를 실질적으로 보유하고 있었습니다. 제출서류에는 해당 매도가 Rule 10b5-1 거래계획에 따라 이루어졌으며, 매도된 주식은 제한조건부 주식 단위(RSU)의 가득으로 발생한 세금 원천징수 의무를 충당하기 위해 판매된 것임이 명시되어 있습니다.
서식 및 서명: Form 4는 보고인을 대신해 대리인이 서명했으며 섹션 16 제출에 요구되는 표준 인증 문구가 포함되어 있습니다.
Vente d'initié dans le cadre d'un plan 10b5-1 : Tomoko Yamagishi-Dressler, directrice marketing et administratrice d'Evolus, Inc. (EOLS), a déclaré avoir vendu 5 722 actions ordinaires de la société le 22/08/2025 au prix de 7,51 $ par action. Après la transaction, la personne déclarant détenait bénéficiairement 89 949 actions. Le dépôt indique que la vente a été effectuée conformément à un plan de transaction en vertu de la règle 10b5-1 et que les actions vendues devaient l'être pour couvrir des obligations fiscales résultant de l'attribution de restricted stock units.
Formulaire et signature : Le formulaire Form 4 a été signé par un mandataire agissant au nom de la personne déclarant et contient la formule de certification standard requise pour les dépôts en vertu de la Section 16.
Insider-Verkauf nach 10b5-1-Plan: Tomoko Yamagishi-Dressler, Chief Marketing Officer und Direktorin von Evolus, Inc. (EOLS), meldete den Verkauf von 5.722 Stammaktien des Unternehmens am 22.08.2025 zu je $7,51. Nach der Transaktion hielt die meldende Person wirtschaftlich 89.949 Aktien. Die Meldung weist darauf hin, dass der Verkauf im Rahmen eines Rule 10b5-1-Handelsplans erfolgte und die verkauften Aktien zur Deckung von Steuerabzugsverpflichtungen aus dem Vesting von Restricted Stock Units verkauft werden mussten.
Formular und Unterschrift: Das Formular Form 4 wurde von einem Bevollmächtigten im Namen der meldenden Person ausgeführt und enthält die üblichen Bestätigungsformulierungen, die für Meldungen nach Section 16 erforderlich sind.
- Sale was conducted under a Rule 10b5-1 trading plan, indicating it was prearranged and not opportunistic trading
- Clear disclosure of amounts and price: 5,722 shares sold at $7.51, leaving 89,949 shares beneficially owned
- Sale purpose explicitly stated as covering tax withholding for vested restricted stock units
- Insider reduced holdings by 5,722 shares, which lowers the reporting person's direct stake
- Transaction occurred at $7.51, which may be below or above current market levels (market context not provided in filing)
Insights
TL;DR: A routine, prearranged sale of 5,722 shares under a 10b5-1 plan to satisfy tax withholding; holding remains material at 89,949 shares.
The transaction is explicitly described as effected under a Rule 10b5-1 trading plan and tied to tax withholding for vested restricted stock units, which signals a non-discretionary, pre-planned disposition rather than opportunistic insider trading. The sale amount (5,722 shares at $7.51) and resulting beneficial ownership (89,949 shares) are disclosed clearly, meeting Section 16 transparency requirements. This is a standard executive liquidity event and does not, on its face, indicate a change in company fundamentals.
TL;DR: Disclosure aligns with governance best practices: use of 10b5-1 plan and timely Form 4 filing; signature executed by attorney-in-fact.
The filing documents: reporter role (Officer/CMO and Director), the specific share amount sold, price per share, and the pro forma beneficial ownership after the sale. The explanation states the sale covered tax withholding from vested RSUs and was executed under an approved 10b5-1 plan, which supports procedural compliance. Execution by an attorney-in-fact is noted and the form contains the required certification language.
Vendita da insider in base al piano 10b5-1: Tomoko Yamagishi-Dressler, Chief Marketing Officer e amministratore di Evolus, Inc. (EOLS), ha comunicato la vendita di 5.722 azioni della società in data 22/08/2025 al prezzo di $7,51 per azione. Dopo l'operazione, la persona che ha presentato la comunicazione deteneva beneficiariamente 89.949 azioni. La segnalazione specifica che la vendita è avvenuta ai sensi di un piano di negoziazione secondo la Rule 10b5-1 e che le azioni vendute erano necessarie per coprire obblighi fiscali derivanti dal consolidamento di restricted stock units.
Modulo e firma: Il modulo Form 4 è stato firmato da un procuratore in nome della persona che ha presentato la comunicazione e contiene la consueta dichiarazione di certificazione richiesta per le comunicazioni ai sensi della Sezione 16.
Venta de insider bajo un plan 10b5-1: Tomoko Yamagishi-Dressler, directora y Chief Marketing Officer de Evolus, Inc. (EOLS), informó la venta de 5.722 acciones ordinarias de la compañía el 22/08/2025 a $7,51 por acción. Tras la transacción, la persona informante poseía beneficiariamente 89.949 acciones. La presentación indica que la venta se realizó conforme a un plan de negociación bajo la Regla 10b5-1 y que las acciones vendidas fueron necesarias para cubrir retenciones fiscales derivadas del otorgamiento de unidades de acciones restringidas (RSU).
Formulario y firma: El Formulario 4 fue ejecutado por un apoderado en nombre de la persona informante e incluye el lenguaje de certificación estándar exigido para las presentaciones conforme a la Sección 16.
10b5-1 계획에 따른 내부자 매도: Evolus, Inc.(EOLS)의 최고마케팅책임자 겸 이사인 Tomoko Yamagishi-Dressler는 2025년 8월 22일 회사 보통주 5,722주를 주당 $7.51에 매도한 사실을 보고했습니다. 거래 후 보고인은 89,949주를 실질적으로 보유하고 있었습니다. 제출서류에는 해당 매도가 Rule 10b5-1 거래계획에 따라 이루어졌으며, 매도된 주식은 제한조건부 주식 단위(RSU)의 가득으로 발생한 세금 원천징수 의무를 충당하기 위해 판매된 것임이 명시되어 있습니다.
서식 및 서명: Form 4는 보고인을 대신해 대리인이 서명했으며 섹션 16 제출에 요구되는 표준 인증 문구가 포함되어 있습니다.
Vente d'initié dans le cadre d'un plan 10b5-1 : Tomoko Yamagishi-Dressler, directrice marketing et administratrice d'Evolus, Inc. (EOLS), a déclaré avoir vendu 5 722 actions ordinaires de la société le 22/08/2025 au prix de 7,51 $ par action. Après la transaction, la personne déclarant détenait bénéficiairement 89 949 actions. Le dépôt indique que la vente a été effectuée conformément à un plan de transaction en vertu de la règle 10b5-1 et que les actions vendues devaient l'être pour couvrir des obligations fiscales résultant de l'attribution de restricted stock units.
Formulaire et signature : Le formulaire Form 4 a été signé par un mandataire agissant au nom de la personne déclarant et contient la formule de certification standard requise pour les dépôts en vertu de la Section 16.
Insider-Verkauf nach 10b5-1-Plan: Tomoko Yamagishi-Dressler, Chief Marketing Officer und Direktorin von Evolus, Inc. (EOLS), meldete den Verkauf von 5.722 Stammaktien des Unternehmens am 22.08.2025 zu je $7,51. Nach der Transaktion hielt die meldende Person wirtschaftlich 89.949 Aktien. Die Meldung weist darauf hin, dass der Verkauf im Rahmen eines Rule 10b5-1-Handelsplans erfolgte und die verkauften Aktien zur Deckung von Steuerabzugsverpflichtungen aus dem Vesting von Restricted Stock Units verkauft werden mussten.
Formular und Unterschrift: Das Formular Form 4 wurde von einem Bevollmächtigten im Namen der meldenden Person ausgeführt und enthält die üblichen Bestätigungsformulierungen, die für Meldungen nach Section 16 erforderlich sind.
FAQ
What did Tomoko Yamagishi-Dressler report on Form 4 for EOLS?
Was the sale made under a 10b5-1 trading plan?
Why were the shares sold according to the filing?
What is the reporting person's role at Evolus (EOLS)?
Who signed the Form 4?
